MeiraGTx Holdings plc

MGTXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$81.4M

▲ 144.6% YoY

Net Income

-$114.2M

▲ 22.7% YoY

EPS

$-1.42

▲ 33.0% YoY

Cash

$65.9M

▼ 36.4% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.